GB2211502B - Derivatives of monophosphoryl lipid a and process for preparation - Google Patents

Derivatives of monophosphoryl lipid a and process for preparation

Info

Publication number
GB2211502B
GB2211502B GB8824330A GB8824330A GB2211502B GB 2211502 B GB2211502 B GB 2211502B GB 8824330 A GB8824330 A GB 8824330A GB 8824330 A GB8824330 A GB 8824330A GB 2211502 B GB2211502 B GB 2211502B
Authority
GB
United Kingdom
Prior art keywords
derivatives
preparation
monophosphoryl lipid
monophosphoryl
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8824330A
Other languages
English (en)
Other versions
GB8824330D0 (en
GB2211502A (en
Inventor
Kent R Myers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ribi Immunochem Research Inc
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of GB8824330D0 publication Critical patent/GB8824330D0/en
Publication of GB2211502A publication Critical patent/GB2211502A/en
Application granted granted Critical
Publication of GB2211502B publication Critical patent/GB2211502B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
    • C07K17/02—Peptides being immobilised on, or in, an organic carrier
    • C07K17/06—Peptides being immobilised on, or in, an organic carrier attached to the carrier via a bridging agent
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
GB8824330A 1987-10-22 1988-10-18 Derivatives of monophosphoryl lipid a and process for preparation Expired - Lifetime GB2211502B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/112,742 US4987237A (en) 1983-08-26 1987-10-22 Derivatives of monophosphoryl lipid A

Publications (3)

Publication Number Publication Date
GB8824330D0 GB8824330D0 (en) 1988-11-23
GB2211502A GB2211502A (en) 1989-07-05
GB2211502B true GB2211502B (en) 1992-02-19

Family

ID=22345625

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8824330A Expired - Lifetime GB2211502B (en) 1987-10-22 1988-10-18 Derivatives of monophosphoryl lipid a and process for preparation

Country Status (10)

Country Link
US (1) US4987237A (https=)
JP (1) JPH075623B2 (https=)
BE (1) BE1003250A5 (https=)
CA (1) CA1308711C (https=)
CH (1) CH676715A5 (https=)
DE (1) DE3836006C2 (https=)
FR (1) FR2622192A1 (https=)
GB (1) GB2211502B (https=)
IT (1) IT1230592B (https=)
NL (1) NL8802595A (https=)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5158939A (en) * 1989-07-21 1992-10-27 Wisconsin Alumni Research Foundation Method of stimulating the immune systems of animals and compositions useful therefor
WO1991001146A1 (en) * 1989-07-14 1991-02-07 Praxis Biologics, Inc. Cytokine and hormone carriers for conjugate vaccines
US5498708A (en) * 1989-07-18 1996-03-12 Montefiore Medical Center Method of synthesizing polyesters
EP0482206A4 (en) * 1990-04-12 1992-08-19 Japan Tobacco Inc. 4,6-o-hydroxyphosphorylglucosamine derivative
US5653974A (en) * 1990-10-18 1997-08-05 Board Of Regents,The University Of Texas System Preparation and characterization of liposomal formulations of tumor necrosis factor
US5164375A (en) * 1991-09-27 1992-11-17 Merck & Company, Inc. Antifungal agent
US5648343A (en) * 1994-02-28 1997-07-15 The University Of Georgia Research Foundation Method for treating LPS-mediated disorders
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
US5681824A (en) * 1995-06-05 1997-10-28 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US6290971B1 (en) * 1995-06-15 2001-09-18 Aventis Pasteur Limited Adjuvant compositions comprising a mineral salt and another immunostimulating compound
GB9706957D0 (en) * 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) * 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
US20040002068A1 (en) 2000-03-01 2004-01-01 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
EP2000144A1 (en) 2000-05-19 2008-12-10 Corixa Corporation Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono-and disaccharide-based compounds
US20030139356A1 (en) * 2001-05-18 2003-07-24 Persing David H. Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7361352B2 (en) * 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
EP1482795B1 (en) * 2002-02-04 2009-11-11 Corixa Corporation New immunoeffector compounds
US6911434B2 (en) * 2002-02-04 2005-06-28 Corixa Corporation Prophylactic and therapeutic treatment of infectious and other diseases with immunoeffector compounds
WO2003073827A2 (en) * 2002-02-28 2003-09-12 Corixa Corporation Methods of modulating dendritic cells using adjuvants
US20030224013A1 (en) * 2002-04-19 2003-12-04 Cole Garry T. Methods for protection against Coccidioides spp. infection using Coccidioides spp. urea amidohydrolase (Ure) protein
RU2340621C2 (ru) 2002-07-08 2008-12-10 Корикса Корпорейшн Способы получения аминоалкилглюкозаминидфосфатов и дисахаридных иммуноэффекторов и их промежуточных соединений
CA2512108C (en) 2003-01-06 2013-04-02 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
US7960522B2 (en) 2003-01-06 2011-06-14 Corixa Corporation Certain aminoalkyl glucosaminide phosphate compounds and their use
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
WO2006073921A2 (en) * 2004-12-30 2006-07-13 The Rockefeller University Compositions and methods for enhanced dendritic cell maturation and function
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
US7622128B2 (en) * 2005-12-13 2009-11-24 University Of Washington Porphyromonas gingivalis 1435/1449 LPS as an immune modulator
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
PT2468300T (pt) 2006-09-26 2018-01-30 Infectious Disease Res Inst Composição para vacina contendo adjuvante sintético
EP2173376B1 (en) * 2007-08-02 2015-03-25 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope influenza vaccines
US20090215908A1 (en) * 2007-09-24 2009-08-27 Reliance Life Sciences Pvt. Ltd. Toll like receptor (tlr) signaling antagonist
US20090215710A1 (en) * 2007-09-24 2009-08-27 Reliance Life Sciences Pvt. Ltd. Carbohydrate based toll-like receptor (tlr) antagonists
WO2009073179A2 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
CN102481312B (zh) 2009-06-05 2015-07-15 传染性疾病研究院 合成的吡喃葡萄糖脂佐剂
CA2828068C (en) 2011-02-22 2019-03-19 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
WO2012141984A1 (en) 2011-04-08 2012-10-18 Immune Design Corp. Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
GB201106802D0 (en) 2011-04-21 2011-06-01 Allergy Therapeutics Ltd Process for preparing vaccine composition
KR102136433B1 (ko) 2012-05-16 2020-07-22 이뮨 디자인 코포레이션 Hsv-2 백신
JP6494527B2 (ja) 2013-02-07 2019-04-03 ザ チルドレンズ メディカル センター コーポレーション 肺炎球菌のコロニー形成および／または疾患からの保護を提供するタンパク質抗原
ES2743431T3 (es) 2013-02-20 2020-02-19 Bergen Teknologioverfoering As Vacuna
EP2986303B1 (en) 2013-04-18 2020-02-26 Immune Design Corp. Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
EP3024476A1 (en) 2013-07-26 2016-06-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of bacterial infections
WO2016180852A1 (en) 2015-05-12 2016-11-17 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for preparing antigen-specific t cells from an umbilical cord blood sample
KR20250006307A (ko) 2017-09-13 2025-01-10 사노피 파스퇴르 인간 시토메갈로바이러스 면역원성 조성물
US20190275134A1 (en) 2018-03-12 2019-09-12 Janssen Pharmaceuticals, Inc Vaccines against urinary tract infections
CN113195520A (zh) 2018-08-24 2021-07-30 挪威西部创新股份有限公司 作为抗腹泻疫苗抗原的热稳定肠毒素突变体
MX2022004061A (es) 2019-10-02 2022-07-19 Janssen Vaccines & Prevention Bv Peptidos de estafilococo y metodos de uso.
LT4090363T (lt) 2020-01-16 2024-09-25 Janssen Pharmaceuticals, Inc. Fimh mutantas, kompozicijos su juo ir jų panaudojimas
US11725028B2 (en) 2021-01-12 2023-08-15 Janssen Pharmaceuticals, Inc. FimH mutants, compositions therewith and use thereof
KR20230164108A (ko) 2021-04-01 2023-12-01 얀센 파마슈티칼즈, 인코포레이티드 E. coli O18 생물접합체의 생산

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0414725Y2 (https=) * 1980-09-30 1992-04-02
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
JPS62129293A (ja) * 1985-11-28 1987-06-11 Toho Yakuhin Kogyo Kk 親水性のリピドａ単糖類縁体
JPS62195396A (ja) * 1986-02-20 1987-08-28 Toho Yakuhin Kogyo Kk 親水性及び疎水性の基を置換したりピドａ単糖類縁体

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Bact. Endotoxin" J.Y. Hamma (ed.) (Verlag Chemie, Weinheim,Germany: 1984) pp. 61-100 *
ACS Sym. Ser. 231 (Bact. Liposaccharides) 237-54 (1983) *
Infect. Immun. 44(2) 421-33 (1984) *
JP 59048497 *
Recl. J. R. Neth. Chem. Soc. 102(10) 438-49 (1983) *
Tetrahedron Letters 24(19) 2011-4 (1983) *

Also Published As

Publication number Publication date
NL8802595A (nl) 1989-05-16
FR2622192A1 (fr) 1989-04-28
US4987237A (en) 1991-01-22
FR2622192B1 (https=) 1994-11-10
GB8824330D0 (en) 1988-11-23
BE1003250A5 (fr) 1992-02-11
CH676715A5 (https=) 1991-02-28
IT8822399A0 (it) 1988-10-21
DE3836006C2 (de) 1996-07-11
JPH01146891A (ja) 1989-06-08
DE3836006A1 (de) 1989-05-03
JPH075623B1 (https=) 1995-01-25
CA1308711C (en) 1992-10-13
GB2211502A (en) 1989-07-05
JPH075623B2 (ja) 1995-01-25
IT1230592B (it) 1991-10-28

Similar Documents

Publication Publication Date Title
GB2211502B (en) Derivatives of monophosphoryl lipid a and process for preparation
GR880100512A (en) Preparation method of 4-ammonium derivatives of epipodophyllotoxinc glucosite
YU20288A (en) Process for preparing derivatives of adenosyn 5-carboxamides
HU896774D0 (en) Process for preparation of condensated-quinoline-derivatives
HU896728D0 (en) Process for preparation of mono-n-alkylated polyzamacrocyclides
YU16688A (en) Process for obtaining derivatives of benzoyl-urea
IL85706A0 (en) Process for the preparation of nitroethene derivatives
CS708787A1 (en) Method of 5-azacytosines preparation
EG18591A (en) Process for preparing of azolidinedione derivatives
EP0312922A3 (en) Oxethylsulfonyl-nitro- or -amino-benzoic acids and process for their preparation
GR880100265A (en) Preparation process of quinolinothioether
HU900159D0 (en) Process for preparation of tetrazide-derivatives
YU86189A (en) Process for obtaining derivatives of benzoilurea
HU900888D0 (en) Process for preparation of 1-arylsulfonyl-pyrrolidin-2-thion and 1-arylsulfonyl-piperidin-2-thion derivatives
GB8720773D0 (en) Preparation of derivatives
ZA881990B (en) Dicyanoethylaryl derivatives and process for their preparation
CS435387A1 (en) Method of 3-phenylalkanales preparation
GB8822146D0 (en) Process for preparation of n-aralkylated aminofluoranes
YU163187A (en) Process for preparing derivatives of 10-dihydro-10-deoxo-11-azaeritronolides
YU193687A (en) Process for preparing derivatives of l-aspartyl-l-phenylalanyn
BG43254A1 (en) Derivatives of 1- benzhydrylpiperazine and method for their preparation
BG43923A1 (en) Derivatives of n- substituted- 2- oxazolidones and method for their preparation
GB8822386D0 (en) Process for preparation of cyclopentene derivatives
CS59588A2 (en) Method of oxetanocine derivative preparation
CS340888A2 (en) Method of oxetanocine derivative preparation

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20081017